Jeet Mahal
Operationeel Directeur bij JASPER THERAPEUTICS, INC.
Vermogen: 529 691 $ op 30-04-2024
Actieve functies van Jeet Mahal
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
JASPER THERAPEUTICS, INC. | Operationeel Directeur | 21-03-2022 | - |
Investor Relations Contact | 01-12-2019 | - | |
Financieel Directeur/CFO | 01-12-2019 | 25-09-2023 | |
Bedrijfssecretaris | 01-12-2019 | - |
Loopbaan van Jeet Mahal
Eerdere bekende functies van Jeet Mahal
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-12-2009 | 01-12-2019 |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Corporate Officer/Principal | - | - |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | - | - |
Opleiding van Jeet Mahal
University of California, Berkeley | Undergraduate Degree |
Illinois Institute of Technology | Graduate Degree |
North Carolina State University | Graduate Degree |
The Fuqua School of Business | Masters Business Admin |
Duke University | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 11 |
Operationeel
Corporate Officer/Principal | 4 |
Graduate Degree | 2 |
Masters Business Admin | 2 |
Sectoraal
Consumer Services | 6 |
Health Technology | 5 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
JASPER THERAPEUTICS, INC. | Finance |
JOHNSON & JOHNSON | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
- Beurs
- Insiders
- Jeet Mahal
- Ervaring